# 18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes

> **NCT03530176** · NA · COMPLETED · sponsor: **University of Alberta** · enrollment: 98 (actual)

## Conditions studied

- Atherosclerosis
- Complications of Diabetes Mellitus

## Interventions

- **RADIATION:** 18Fluoride-Sodium Fluoride radio-isotope

## Key facts

- **NCT ID:** NCT03530176
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2017-10-15
- **Final completion:** 2017-10-15
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530176, "18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03530176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*